|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2000-2-16
|
|
pubmed:abstractText |
To evaluate the efficacy and safety of short-term oral treatment with the antioxidant thioctic acid (TA) on neuropathic symptoms and deficits in patients with Type 2 diabetes mellitus with symptomatic polyneuropathy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0742-3071
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1040-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10656234-Aged,
pubmed-meshheading:10656234-Antioxidants,
pubmed-meshheading:10656234-Diabetes Mellitus, Type 2,
pubmed-meshheading:10656234-Diabetic Nephropathies,
pubmed-meshheading:10656234-Double-Blind Method,
pubmed-meshheading:10656234-Female,
pubmed-meshheading:10656234-Humans,
pubmed-meshheading:10656234-Male,
pubmed-meshheading:10656234-Middle Aged,
pubmed-meshheading:10656234-Pilot Projects,
pubmed-meshheading:10656234-Placebos,
pubmed-meshheading:10656234-Thioctic Acid
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy.
|
|
pubmed:affiliation |
Deutsches Diabetes-Forschungsinstitut an der Heinrich-Heine-Universität, Düsseldorf, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
